Cargando…

Clinical benefit and tolerability of adjuvant intraperitoneal chemotherapy in patients who have or have not received neoadjuvant chemotherapy for advanced ovarian cancer

BACKGROUND: Adjuvant chemotherapy using intraperitoneal (IP) treatment has demonstrated survival benefit over intravenous (IV) therapy alone in patients treated with upfront debulking surgery for advanced stage ovarian cancer. Neoadjuvant chemotherapy followed by interim surgery and adjuvant chemoth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meghal, Trishala, Dave, Vishangi, Tang, Horace, Kumar, Vivek, Xu, Yiqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2019
Materias:	Retrospective Cohort Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556590/ https://www.ncbi.nlm.nih.gov/pubmed/31205865 http://dx.doi.org/10.5306/wjco.v10.i5.201

Ejemplares similares

Elemene-containing hyperthermic intraperitoneal chemotherapy combined with chemotherapy for elderly patients with peritoneal metastatic advanced gastric cancer
por: Chen, Zhi-Xiong, et al.
Publicado: (2022)

Comparison of hyperthermic intraperitoneal chemotherapy regimens for treatment of peritoneal-metastasized colorectal cancer
por: Spiegelberg, Julia, et al.
Publicado: (2020)

Intraoperative intraperitoneal chemotherapy increases the incidence of anastomotic leakage after anterior resection of rectal tumors
por: Wang, Zhi-Jie, et al.
Publicado: (2019)

Neutropenia in colorectal cancer treated with oxaliplatin-based hyperthermic intraperitoneal chemotherapy: An observational cohort study
por: Cashin, Peter H, et al.
Publicado: (2020)

Predictive factors of histological response of colorectal liver metastases after neoadjuvant chemotherapy
por: Serayssol, Chloé, et al.
Publicado: (2019)

Role of adjuvant chemotherapy on recurrence and survival in patients with resected ampulla of Vater carcinoma
por: Park, Se Jun, et al.
Publicado: (2023)

Comparison of tumor regression grading systems for locally advanced gastric adenocarcinoma after neoadjuvant chemotherapy
por: Liu, Zi-Ning, et al.
Publicado: (2021)

Comparison of efficacy between adjuvant chemotherapy and chemoradiation therapy for pancreatic cancer: AJCC stage-based approach
por: You, Min Su, et al.
Publicado: (2020)

Neoadjuvant VS adjuvant chemotherapy in patients with locally advanced breast cancer; a retrospective cohort study
por: Akbari, Mohammad-esmaeil, et al.
Publicado: (2022)

Consolidation chemotherapy with capecitabine after neoadjuvant chemoradiotherapy in high-risk patients with locally advanced rectal cancer: Propensity score study
por: Sheng, Xue-Qing, et al.
Publicado: (2022)

Fat clearance and conventional fixation identified ypN0 rectal cancers following intermediate neoadjuvant radiotherapy have similar long-term outcomes
por: Chen, Nan, et al.
Publicado: (2019)

Could neoadjuvant chemotherapy increase postoperative complication risk of laparoscopic total gastrectomy? A mono-institutional propensity score-matched study in China
por: Cui, Hao, et al.
Publicado: (2021)

Positron emission tomography complete metabolic response as a favorable prognostic predictor in esophageal cancer following neoadjuvant chemotherapy with docetaxel/cisplatin/5-fluorouracil
por: Suzuki, Kosuke, et al.
Publicado: (2021)

Neutrophil-to-lymphocyte ratio and carbohydrate antigen 19-9 as prognostic markers for advanced pancreatic cancer patients receiving first-line chemotherapy
por: Shin, Kabsoo, et al.
Publicado: (2021)

First-line chemotherapy in very elderly patients with metastatic pancreatic cancer: Gemcitabine monotherapy vs combination chemotherapy
por: Han, Sung Yong, et al.
Publicado: (2020)

Comparison of open and closed hyperthermic intraperitoneal chemotherapy: Results from the United States hyperthermic intraperitoneal chemotherapy collaborative
por: Leiting, Jennifer L, et al.
Publicado: (2020)

Prognostic factors and predictors of postoperative adjuvant transcatheter arterial chemoembolization benefit in patients with resected hepatocellular carcinoma
por: Chen, Ming-Yu, et al.
Publicado: (2020)

Repeated cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy in patients with peritoneal carcinomatosis: A retrospective cohort study
por: Paasch, C., et al.
Publicado: (2021)

Oral chemotherapy for second-line treatment in patients with gemcitabine-refractory advanced pancreatic cancer
por: Park, Se Jun, et al.
Publicado: (2019)

Do peripartum and postmenopausal women with primary liver cancer have a worse prognosis? A nationwide cohort in Taiwan
por: Tseng, Guan-Woei, et al.
Publicado: (2021)

Risk stratification of patients who present with chest pain and have normal troponins using a machine learning model
por: Shafiq, Muhammad, et al.
Publicado: (2022)

Older adults with acute severe ulcerative colitis have similar steroid non-response and colectomy rates as younger adults
por: Subhaharan, Deloshaan, et al.
Publicado: (2023)

Different oncological features of colorectal cancer codon-specific KRAS mutations: Not codon 13 but codon 12 have prognostic value
por: Ahn, Hong-Min, et al.
Publicado: (2023)

Treatment times in breast cancer patients receiving neoadjuvant vs adjuvant chemotherapy: Is efficiency a benefit of preoperative chemotherapy?
por: Melchior, Nicole M., et al.
Publicado: (2020)

Prognostic effect of excessive chemotherapy cycles for stage II and III gastric cancer patients after D2 + gastrectomy
por: Li, Yi-Fan, et al.
Publicado: (2023)

Elderly patients (≥ 80 years) with acute calculous cholangitis have similar outcomes as non-elderly patients (< 80 years): Propensity score-matched analysis
por: Chan, Kai Siang, et al.
Publicado: (2021)

Avoiding breast cancer surgery in a select cohort of complete responders to neoadjuvant chemotherapy: The long-term outcomes
por: Apte, Anuradha, et al.
Publicado: (2021)

Impact of interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer patients
por: Mei, Shi-Wen, et al.
Publicado: (2020)

Do we have biomarkers to predict response to neoadjuvant and adjuvant chemotherapy and immunotherapy in bladder cancer?
por: Wezel, Felix, et al.
Publicado: (2017)

Evaluating the benefit of adjuvant chemotherapy in patients with ypT0–1 rectal cancer treated with preoperative chemoradiotherapy
por: Jeon, Ye Won, et al.
Publicado: (2021)

Nomograms and risk score models for predicting survival in rectal cancer patients with neoadjuvant therapy
por: Wei, Fang-Ze, et al.
Publicado: (2020)

Impact factors of lymph node retrieval on survival in locally advanced rectal cancer with neoadjuvant therapy
por: Mei, Shi-Wen, et al.
Publicado: (2020)

Adjuvant Bidirectional Chemotherapy Using an Intraperitoneal Port
por: Sugarbaker, Paul H., et al.
Publicado: (2012)

Impact of laparoscopic liver resection on bleeding complications in patients receiving antithrombotics
por: Fujikawa, Takahisa, et al.
Publicado: (2017)

Chemotherapy Treatment Modifications During the COVID-19 Outbreak at a Community Cancer Center in New York City
por: Lin, Dong D., et al.
Publicado: (2020)

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: Girshally, Ramy, et al.
Publicado: (2016)

Benefits of laparoscopy-assisted ileostomy in colorectal cancer patients with bowel obstruction
por: Wang, Yi-Jie, et al.
Publicado: (2023)

Benefit of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy and Bidirectional Chemotherapy for Patients with Gastric Cancer with Peritoneal Carcinomatosis Considering Cytoreductive Surgery
por: Yu, Hsin-Hsien, et al.
Publicado: (2023)

Timing of surgery after neoadjuvant chemotherapy for gastric cancer: Impact on outcomes
por: Liu, Yi, et al.
Publicado: (2018)

Efficacy and prognostic factors of neoadjuvant chemotherapy for triple-negative breast cancer
por: Ding, Feng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vvla4k54kn1ed8u83afkkl1ueg